TheLancetEndo Profile Banner
The Lancet Diabetes & Endocrinology Profile
The Lancet Diabetes & Endocrinology

@TheLancetEndo

Followers
53K
Following
1K
Media
4K
Statuses
13K

Your leading source of international, cutting-edge research, review, and opinion in clinical diabetes and endocrinology. IF=41·8.

London
Joined November 2013
Don't wanna be here? Send us removal request.
@TheLancetEndo
The Lancet Diabetes & Endocrinology
27 days
The December Issue of @TheLancetEndo is now online, featuring familial hypercholesterolaemia, chronic kidney disease, type 2 diabetes, cyclic Cushing’s syndrome, primary aldosteronism, type 1 diabetes, menopause, obesity, iodine deficiency, & much more https://t.co/1LW4xvaLB1
0
8
32
@TheLancetEndo
The Lancet Diabetes & Endocrinology
16 hours
Our 4 paper Series on #PrecisionMedicine provides a framework for its integration in cardiometabolic disease, discusses the heterogeneity of #diabetes and #obesity, and explores the implications for its adoption in #LMICs. To find out more visit
Tweet card summary image
thelancet.com
Obesity and diabetes are multifaceted and complex conditions, resulting from a combination of intrinsic and extrinsic factors. However, current approaches to prevention, screening and treatment still...
0
3
19
@TheLancetEndo
The Lancet Diabetes & Endocrinology
24 hours
Although heterozygous #familial #hypercholesterolaemia represents one of the most common monogenic conditions in the general population, homozygous familial hypercholesterolaemia is much rarer, occurring in between 1/160 000 & 1/450 000 individuals https://t.co/MP5vATtZp0 #ASCVD
0
3
17
@TheLancetEndo
The Lancet Diabetes & Endocrinology
2 days
#Diabetes-related #foot #ulcers (DFUs) continue to inflict a harmful toll on people with diabetes due to the medical treatments and lifestyle changes needed to heal these lesions or, in the case of healing failure, limb loss through amputation https://t.co/PyIAbUNQuP #T1D #T2D
0
9
35
@TheLancetEndo
The Lancet Diabetes & Endocrinology
2 days
People with type 2 #diabetes are likely to be more susceptible to adverse health effects from PM2·5, which further amplifies #pollution-related #cardiovascular risk https://t.co/EKFS234XVV #T2D #AirPollution #CVD
2
70
284
@TheLancetEndo
The Lancet Diabetes & Endocrinology
2 days
For much of the 20th century, the diagnosis of adrenal tumours, defined as enlarged or atypical-appearing adrenal lesions that can be benign or malignant, relied on clinical suspicion of large palpable masses, hormonal manifestations, or autopsy findings https://t.co/mwjeqzstQ9.
Tweet card summary image
thelancet.com
Adrenal tumours have become a common incidental finding in the radiological evaluation of patients. Estimates suggest that 1–10% of the general population currently harbours an adrenal tumour,...
0
2
11
@TheLancet
The Lancet
3 days
Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial https://t.co/H1Kb3FKp3j
0
19
70
@TheLancetEndo
The Lancet Diabetes & Endocrinology
3 days
Although very infrequent, cases of #hypothalamic #obesity are a challenging, often intractable medical condition, that can also help to elucidate mechanisms of obesity and eventually identify therapeutic targets https://t.co/3Be0ZzDvWp #hyperphagia
0
3
30
@TheLancetEndo
The Lancet Diabetes & Endocrinology
3 days
Male #hypogonadism caused by an intrinsic & often irreversible HPT pathology is called organic (also termed classical) hypogonadism. Organic hypogonadism has a straightforward, established diagnostic & treatment pathway https://t.co/k5ZVLahhjz #testosterone #MensHealth
0
14
42
@TheLancetEndo
The Lancet Diabetes & Endocrinology
3 days
The YOMEGA study is the first RCT providing long-term data comparing #weightloss, metabolic outcomes, and #safety with one anastomosis gastric bypass versus standard Roux-en-Y gastric bypass. Read the 5 years follow-up data here:
Tweet card summary image
thelancet.com
OAGB was not inferior to RYGB regarding percentage excess BMI loss at 5 years with similar metabolic outcomes. The high rate of clinical gastro-oesophageal reflux disease after OAGB raises questions...
0
6
27
@TheLancet
The Lancet
4 days
The rise of ultra-processed foods is damaging public health, fuelling chronic diseases worldwide, and deepening health inequalities. Urgent, coordinated global action is needed to address the UPF challenge. Find out more in an Editorial ➡️ https://t.co/6hBuTB5XCv
18
233
450
@TheLancetEndo
The Lancet Diabetes & Endocrinology
4 days
#Tirzepatide added to basal insulin improved glycaemic control and was generally well tolerated, providing evidence to support its potential therapeutic use in patients with type 2 #diabetes in China https://t.co/A2CPLlS5l3 #T2D
1
10
64
@TheLancetEndo
The Lancet Diabetes & Endocrinology
4 days
The findings support arguments for widespread early use of #SGLT2 inhibitors to reduce the global burden of #kidney disease, to simplify current guidance on whom to treat, and to discourage routine remeasurement of eGFR after initiation https://t.co/e1njA9ojwQ #CKD #OpenAccess
Tweet card summary image
thelancet.com
SGLT2 inhibition reduces risk of acute and chronic kidney outcomes irrespective of the size of the acute dip in eGFR. Kidney benefits are evident irrespective of diabetes status, heart failure...
0
5
30
@TheLancetEndo
The Lancet Diabetes & Endocrinology
5 days
There is a major research gap as to the optimal management strategy for type 2 diabetes in adolescents and young adults, given that current models of care appear to not work as well in this age group. For more: https://t.co/KikG2M0rKu #diabetes
Tweet card summary image
thelancet.com
Type 2 diabetes diagnosed in childhood or early adulthood is termed early-onset type 2 diabetes. Cases of early-onset type 2 diabetes are increasing rapidly globally, alongside rising obesity....
0
2
18
@TheLancetEndo
The Lancet Diabetes & Endocrinology
5 days
The association between unsuppressed #renin following medical therapy for primary #aldosteronism and reduced risk of #cardiovascular events and all-cause mortality suggests that renin normalisation might serve as a therapeutic target https://t.co/y0iWBTIhKf #CVD
Tweet card summary image
thelancet.com
The association between unsuppressed renin following medical therapy for primary aldosteronism and reduced risk of cardiovascular events and all-cause mortality suggests that renin normalisation...
1
1
8
@TheLancetEndo
The Lancet Diabetes & Endocrinology
5 days
Even in specialised centres, cyclic #Cushing's syndrome (cCS) diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes https://t.co/0ZfSwOraBZ #pituitary
Tweet card summary image
thelancet.com
Even in specialised centres, cCS diagnosis and management remain challenging with high rates of spontaneous adrenal insufficiency, inappropriate surgeries, and poor outcomes. Ectopic cCS showed the...
1
0
19
@LancetGastroHep
The Lancet Gastroenterology & Hepatology
5 days
Our January 2026 issue is out now: https://t.co/bK6A0hWWqa Content includes #MASH, #IBD, #PBC, #PSC, #ageing, #diet + more! #GITwitter #MedTwitter #LiverTwitter
0
7
12